As 2025 winds down, I’ve been looking back at the past twelve months – the wins, the challenges, the moments that made us think, and the people who shaped the year. It’s been busy yet energising – and ultimately, a year I’m incredibly proud of.
This year, the pharmaceutical industry has continued shifting beneath our feet – and several developments, in particular have stood out.
One major shift: Veeva Vault CRM – not just another CRM, but the successor to Veeva CRM (on Salesforce) – is now becoming the primary platform for many pharma companies and we’ve been closely tracking its rollout at IGNIFI. You can read more in our Veeva CRM blog.
For pharma clients, this is far more than a simple technology swap. It signals a broader move toward integrated, omnichannel engagement across sales, marketing, medical, and service functions. As a Veeva Content Partner, our certified team is working very closely with Veeva, to understand how Vault CRM unites all customer-facing teams on a single platform. With one shared database, we’re seeing a more unified customer view, more consistent content delivery, and better coordinated outreach across channels – learning how to use this to enhance HCP engagement.
Consequently, our client conversations have evolved. Instead of, “Can we just launch this email campaign?”, we’re helping teams design fully joined-up customer journeys.
And then, of course, there’s AI. As Craig, our Digital Director, articulated in his November blog Beyond the AI Bubble, the conversation is evolving. Increasingly, clients are asking how they can they use AI to inform decisions and personalise engagement. The winners in 2026 will be those who can lay the groundwork: by gathering clean, consented data; building organised content libraries; structuring claims taxonomies; and establishing omnichannel measurement frameworks that tie marketing outputs to real healthcare outcomes. With those foundations, AI can deliver its full potential: more precise, compliant and outcome-driven strategies.
This year’s work was shaped decisively by our clients – across human health and animal health – yet guided at every step by IGNIFI’s strategic creativity, technical and marketing expertise. In our June blog, From product to partner, we saw how pharma brands should go beyond selling products – collaborating closely with healthcare professionals to co-create solutions, ground strategies in clinical insight, and ultimately deliver value-led patient care rather than just commodities.
It’s been fantastic to see that philosophy come to life in our medical education work. We’ve loved supporting medical and commercial teams with meaningful HCP conversations again this year, designing tailored training programmes for rare disease brands, and genuinely co-creating educational content, particularly around biosimilars launches, rather than just delivering standard slide decks or leaflets.
We’ve found ourselves increasingly moving into women’s health. So many conditions affecting women continue to be under-recognised or misdiagnosed, and the impact on time to treatment is profound. Through our own educational content and client project work, we’ve sought to play a small but meaningful role in bridging that gap. Helping one of our clients market a therapy for a rare blood disorder that is frequently misdiagnosed as heavy menstrual bleeding has been extremely rewarding in encouraging earlier diagnosis, intervention and improving equity of care between male and female patients with this rare disease.
We are committed to pushing this further in 2026 – keep an eye on our blog for something new coming soon!
What stands out most of all is how the entire IGNIFI team navigated the year’s challenges and opportunities with integrity, agility and collaborative spirit. We grew in scale but also in cohesion, capability and culture.
We’ve had several significant people-moments this year. I’m delighted to congratulate Frank Taylor, Senior Creative, on his 30-year anniversary. Michelle Johnson, Fulfilment Operative, also celebrated 25 years’ service, and we saw how Sarah Thompson, in our Meet the Team blog, rose from Project Manager to Group Account Director over her 15-year journey with IGNIFI. Their achievements exemplify what longevity, passion and continuous curiosity can accomplish.
We’ve also strengthened our team with some key recruits bringing fresh perspectives and industry experience to help us deliver more effective, forward-looking strategies for our pharma clients:
Lydia Papaioannou joined as Senior Account Manager – with her biomedical-science background and nine years in healthcare agencies.
Suman Kaur stepped into the Account Director role, adding even more strategic firepower to our growing team.
On the recognition side, being shortlisted for Agency of the Year (under 30 headcount) at the PM Society PMi Awards was a real boost.
Being part of the Veterinary Marketing Association Awards – not just as attendees but as sponsors – felt like an important milestone. After more than 15 years of dedication to animal health communications, our involvement reaffirmed our commitment to excellence in the sector.
We’re also proud to hold onto our EcoVadis Silver Medal, putting us in the top 15% of companies globally for sustainability, demonstrating our strong commitment across environment, ethics, labour, and responsible procurement.
We’ve always believed that doing good is part of doing well – and 2025 was no exception.
We continued supporting Anthony Nolan, the life-saving stem cell register charity, through employee fundraising initiatives.
We offered pro bono support for StreetVet's Big Give Christmas Campaign, donating our creative and comms expertise to help people experiencing homelessness care for their pets at Christmas.
And locally, we swapped out our usual Secret Santa gifts to instead support children’s charity, Love, Amelia, with their Big Toy appeal.
These moments remind me that business isn’t just about marketing goals or revenue targets – it's about being part of a bigger picture.
As I look ahead to 2026, I feel energised – and I can feel that buzz in the team too. We’re doubling down on what works: combining our creative strength with expert technical capability and deep healthcare know-how. We’ll continue leaning into AI developments, guiding clients through CRM migrations like Veeva Vault, and supporting meaningful engagement with healthcare professionals.
But above all, we’ll continue investing in our people, that tight-knit, clever and gritty team that makes IGNIFI what it is. Together, we’ll continue creating work that matters not just for our clients, but for our team and the communities we care about.
So, here’s to another year of growth, change and impact – and here’s a heartfelt thank you to every member of the IGNIFI team, to our clients, and to all of you who’ve supported us along the way.
© IGNIFI 2025
IGNIFI Limited Registered office: 87-88 Turnmill Street, London, England, EC1M 5QU
Company number: 2128733
Registered VAT number: 357 1506 56
